<- Go Home

Fleury S.A.

Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.

Market Cap

BRL 7.9B

Volume

3.3M

Cash and Equivalents

BRL 9.7M

EBITDA

BRL 1.9B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

BRL 2.3B

Profit Margin

26.61%

52 Week High

BRL 18.10

52 Week Low

BRL 12.48

Dividend

8.28%

Price / Book Value

1.53

Price / Earnings

12.54

Price / Tangible Book Value

-10.99

Enterprise Value

BRL 11.2B

Enterprise Value / EBITDA

5.13

Operating Income

BRL 1.3B

Return on Equity

11.67%

Return on Assets

6.05

Cash and Short Term Investments

BRL 2.2B

Debt

BRL 5.4B

Equity

BRL 5.3B

Revenue

BRL 8.5B

Unlevered FCF

BRL 1.1B

Sector

Health Care Providers and Services

Category

N/A

Company Stock Pitches